SCHEMBL24966152

SCHEMBL24966152

C[C@H](c1ccccc1)n1nccc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
TDP1 Q9NUW8 1/20 0.53
BRD4 O60885 6/20 0.47
FAAH O00519 4/20 0.47
KDM5A P29375 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
MAPK1 P28482 1/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CASP1 P29466 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
GABRA1 P14867 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28348292 1.00 ALDH1A1 (0.53) ALDH1A1TDP1BRD4FAAHKDM5A
SCHEMBL24966148 0.89 BRD4 (0.46) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL28206403 0.89 BRD4 (0.49) ALDH1A1TDP1BRD4FAAHKDM5A
SCHEMBL23234281 0.89 BRD4 (0.46) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL24966182 0.87 BRD4 (0.45) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL24966867 0.84 BRD4 (0.46) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL24966866 0.84 BRD4 (0.43) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL24966063 0.83 BRD4 (0.42) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL23234016 0.82 FAAH (0.44) ALDH1A1TDP1BRD4FAAHMAPK1
SCHEMBL24966076 0.82 BRD4 (0.41) ALDH1A1TDP1BRD4FAAHMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CYP21A2, CYP11B1, CYP11B2 ALDH1A1 413/4885TDP1 3560/4885BRD4 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.